Shands Jacksonville Medical Center INC

Shands Jacksonville Medical Center INC was paid $75.14M by Medicaid between Jan 2018 and Dec 2024, across 546 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.

33Billing provider infoSHANDS JACKSONVILLE MEDICAL CENTER INC
JACKSONVILLE, FL 32209

33aNPI1821186313assigned 10/10/2006

33bProvider typeUrgent Care Clinic/Center

28Total paid$75.14M

24GClaims2,355,155

24DCodes billed546

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Urgent Care Clinic/Center providers in Florida

Rank by total paid#1 of 115

Median peer was paid$106K

This provider vs. median708×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	194,464	$8.89M
2019	432,496	$14.56M
2020	421,209	$12.67M
2021	498,158	$13.86M
2022	493,354	$13.80M
2023	224,263	$7.82M
2024incomplete	91,211	$3.55M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	10%	89,067	78,015	$7.55M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.9%	70,281	59,431	$6.69M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.9%	34,618	28,035	$3.71M
96361	Intravenous infusion, hydration; each additional hour	4.0%	21,724	16,662	$3.03M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	3.1%	12,672	7,285	$2.31M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.5%	40,713	12,134	$1.87M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.2%	21,424	19,688	$1.63M
80048	Basic metabolic panel (calcium, ionized)	2.1%	73,813	53,619	$1.54M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.8%	8,347	6,991	$1.34M
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	1.7%	3,478	249	$1.28M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.6%	12,809	8,820	$1.18M
82962		1.6%	78,723	45,490	$1.17M

534 more codes

96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.5%	24,680	$1.15M
90999	Dialysis (unlisted procedure)	1.5%	2,654	$1.14M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.4%	6,925	$1.07M
J9271	Injection, pembrolizumab, 1 mg	1.3%	744	$1.01M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.3%	7,220	$984K
81003		1.2%	73,482	$871K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	1.2%	90,108	$865K
96375	Therapeutic injection; each additional sequential IV push	1.1%	22,764	$848K
84703		1.1%	36,809	$824K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	13,397	$743K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	27,162	$728K
J1270	Injection, doxercalciferol, 1 mcg	<1%	2,084	$725K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	15,404	$638K
70450	Computed tomography, head or brain; without contrast material	<1%	9,267	$636K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	114,605	$620K
80053	Comprehensive metabolic panel	<1%	39,959	$610K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	9,095	$599K
76818		<1%	10,670	$577K
A4657	Syringe, with or without needle, each	<1%	1,965	$551K
41899	Unlisted procedure, dentoalveolar structures	<1%	1,374	$540K
96415		<1%	3,944	$516K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	4,908	$492K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,331	$484K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,063	$483K
86850		<1%	12,866	$461K
20610		<1%	5,330	$443K
97162		<1%	5,482	$430K
J0604	Cinacalcet, oral, 1 mg, (for esrd on dialysis)	<1%	524	$386K
76830	Ultrasound, transvaginal	<1%	5,387	$372K
67028	Intravitreal injection of a pharmacologic agent	<1%	1,814	$369K
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,521	$357K
J2505	Injection, pegfilgrastim, 6 mg	<1%	625	$352K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	9,101	$349K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	5,738	$338K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,703	$320K
97161		<1%	5,120	$303K
62323		<1%	1,111	$287K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,284	$284K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	50,282	$276K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,202	$274K
87631		<1%	4,221	$269K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,378	$267K
95885		<1%	2,799	$262K
59025	Fetal non-stress test	<1%	10,761	$261K
A9270	Non-covered item or service	<1%	16,019	$257K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	11,110	$252K
81001		<1%	41,275	$247K
01999		<1%	10,729	$244K
71046	Radiologic examination, chest; 2 views	<1%	14,976	$238K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	6,691	$232K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,997	$225K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	710	$207K
87086	Culture, bacterial; quantitative colony count, urine	<1%	18,844	$205K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,336	$198K
77063	Screening digital breast tomosynthesis, bilateral	<1%	8,766	$197K
73630		<1%	9,026	$194K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,585	$193K
95811		<1%	560	$191K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	8,666	$183K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,016	$180K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	383	$170K
36415	Collection of venous blood by venipuncture	<1%	30,730	$160K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,413	$153K
J9299	Injection, nivolumab, 1 mg	<1%	366	$151K
73130		<1%	6,137	$150K
96367		<1%	1,715	$147K
71045	Radiologic examination, chest; single view	<1%	25,165	$147K
76536		<1%	2,269	$144K
J2323	Injection, natalizumab, 1 mg	<1%	152	$143K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,331	$141K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,315	$140K
72197		<1%	865	$138K
84484		<1%	30,044	$138K
76775		<1%	2,589	$138K
84702		<1%	6,324	$133K
J1756	Injection, iron sucrose, 1 mg	<1%	2,971	$133K
73610		<1%	5,458	$130K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,693	$130K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	8,727	$128K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	12,923	$126K
87077		<1%	7,813	$122K
73030		<1%	5,450	$122K
J0897	Injection, denosumab, 1 mg	<1%	1,033	$121K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	686	$116K
82728		<1%	7,491	$114K
95911		<1%	2,351	$113K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,521	$113K
76642		<1%	3,255	$111K
83735		<1%	27,265	$110K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,368	$110K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,500	$110K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	23,494	$109K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,499	$107K
87340		<1%	7,490	$106K
83550		<1%	5,414	$104K
74183		<1%	711	$102K
76770		<1%	1,720	$102K
J1644	Injection, heparin sodium, per 1000 units	<1%	9,024	$101K
36591		<1%	1,382	$101K
96401		<1%	1,536	$101K
84443	Thyroid stimulating hormone (TSH)	<1%	18,527	$101K
73560		<1%	4,109	$100K
83970		<1%	1,755	$100K
74174		<1%	497	$99K
87081		<1%	4,337	$98K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	8,937	$95K
86900		<1%	13,660	$94K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	6,862	$94K
82247		<1%	1,127	$93K
80076		<1%	21,661	$93K
77062		<1%	1,192	$92K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	8,042	$91K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,277	$89K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	8,080	$88K
95886		<1%	613	$88K
80061	Lipid panel	<1%	18,512	$88K
94010		<1%	2,291	$87K
78451		<1%	237	$87K
85027		<1%	14,527	$87K
72141		<1%	1,143	$86K
88307		<1%	551	$85K
71250		<1%	2,332	$85K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,298	$84K
10060		<1%	1,174	$83K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	4,423	$81K
73110		<1%	3,350	$81K
83036	Hemoglobin; glycosylated (A1C)	<1%	21,448	$79K
G0378	Hospital observation service, per hour	<1%	8,719	$79K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	2,942	$78K
43235		<1%	398	$78K
85610		<1%	13,642	$77K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	296	$75K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,203	$74K
72100		<1%	3,153	$74K
93308		<1%	1,482	$74K
84100		<1%	17,519	$73K
87210		<1%	5,955	$72K
73562		<1%	3,578	$71K
70496		<1%	652	$71K
93970		<1%	2,146	$71K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	12,381	$66K
96523		<1%	2,018	$66K
58100		<1%	347	$64K
70491		<1%	797	$61K
96402		<1%	973	$60K
36592		<1%	1,958	$59K
86901		<1%	14,106	$59K
93017		<1%	1,479	$58K
64493		<1%	187	$58K
73564		<1%	3,570	$58K
J3490	Unclassified drugs	<1%	20,380	$57K
81025		<1%	14,856	$57K
73502		<1%	2,748	$57K
93923		<1%	1,088	$56K
93971		<1%	2,025	$55K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	10,389	$54K
72110		<1%	1,319	$54K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,059	$54K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	499	$54K
86780		<1%	7,576	$53K
83690		<1%	14,223	$53K
73221		<1%	627	$53K
87486		<1%	3,804	$52K
72040		<1%	1,471	$52K
88184		<1%	2,624	$50K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,495	$50K
86803		<1%	6,948	$50K
97116		<1%	2,882	$50K
J2704	Injection, propofol, 10 mg	<1%	13,992	$50K
77080		<1%	1,666	$49K
83605		<1%	8,686	$48K
12011		<1%	504	$47K
73590		<1%	2,628	$47K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,368	$46K
86403		<1%	719	$46K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	80	$44K
12001		<1%	570	$44K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,220	$43K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	11,392	$42K
87070		<1%	1,422	$42K
73080		<1%	1,949	$41K
93798		<1%	828	$41K
84439		<1%	4,906	$40K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	771	$40K
74018		<1%	1,886	$39K
70486		<1%	872	$39K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,304	$39K
85730		<1%	7,128	$39K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	1,289	$38K
97165		<1%	2,301	$38K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,506	$38K
87205		<1%	5,161	$37K
93296		<1%	2,917	$37K
J1815	Injection, insulin, per 5 units	<1%	3,590	$37K
82565		<1%	2,224	$37K
96417		<1%	2,249	$36K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	8,393	$36K
27096		<1%	94	$36K
77065	Tomosynthesis, mammo	<1%	1,588	$35K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	541	$34K
36430		<1%	834	$34K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,719	$34K
93458		<1%	85	$33K
80069		<1%	2,135	$33K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	243	$31K
73552		<1%	1,775	$31K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	817	$31K
82550		<1%	4,231	$30K
72170		<1%	1,894	$30K
94726		<1%	1,062	$29K
76882		<1%	575	$29K
88142		<1%	2,672	$29K
82607		<1%	4,958	$28K
73090		<1%	1,591	$28K
96377		<1%	190	$28K
76825		<1%	242	$28K
87536		<1%	2,342	$28K
84112		<1%	224	$28K
86762		<1%	4,623	$28K
73522		<1%	1,282	$27K
57454		<1%	147	$27K
83020		<1%	4,019	$27K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,869	$27K
99214	Doctor's office visit, returning patient (more involved)	<1%	903	$26K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	3,495	$26K
82950		<1%	2,283	$26K
94762		<1%	2,544	$25K
20611		<1%	114	$25K
87088		<1%	8,974	$25K
71271		<1%	519	$25K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,763	$25K
97166		<1%	1,108	$24K
J7030	Infusion, normal saline solution , 1000 cc	<1%	711	$24K
C9257	Injection, bevacizumab, 0.25 mg	<1%	799	$24K
76801		<1%	2,223	$24K
82553		<1%	2,186	$23K
99153	Mod sedat endo service >5yrs	<1%	1,909	$23K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	54	$23K
93880		<1%	719	$22K
73060		<1%	1,207	$22K
83880		<1%	4,128	$22K
99152		<1%	2,058	$22K
96368		<1%	402	$22K
20550		<1%	314	$21K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	466	$21K
93975		<1%	555	$21K
94060		<1%	294	$21K
74178		<1%	308	$20K
84481		<1%	1,839	$20K
72131		<1%	778	$20K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	5,369	$20K
86706		<1%	1,009	$20K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,354	$20K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	136	$20K
77061		<1%	566	$19K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,036	$19K
97535	Self-care/home management training, each 15 minutes	<1%	2,764	$19K
J1453	Injection, fosaprepitant, 1 mg	<1%	320	$19K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,140	$18K
83615		<1%	4,540	$17K
87186		<1%	4,668	$17K
93325		<1%	1,048	$17K
82043		<1%	4,783	$17K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	290	$17K
95912		<1%	422	$17K
58661		<1%	12	$17K
88185		<1%	2,635	$17K
77386		<1%	141	$17K
54160		<1%	22	$16K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,975	$16K
88342		<1%	1,772	$16K
80074		<1%	1,766	$16K
96376		<1%	3,638	$16K
94727		<1%	742	$16K
77002		<1%	406	$16K
72070		<1%	787	$16K
86140		<1%	4,038	$15K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	422	$15K
82330		<1%	3,038	$15K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	576	$15K
82378		<1%	1,771	$14K
85018		<1%	1,229	$14K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	681	$14K
82746		<1%	2,868	$14K
90686		<1%	3,427	$14K
64635		<1%	30	$13K
72052		<1%	330	$13K
77336		<1%	66	$13K
88304		<1%	490	$13K
85379		<1%	2,929	$13K
87040		<1%	3,043	$13K
70498		<1%	467	$12K
83930		<1%	1,940	$12K
J1630	Injection, haloperidol, up to 5 mg	<1%	2,397	$12K
95816		<1%	122	$11K
85651		<1%	3,703	$11K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	164	$11K
C1769	Guide wire	<1%	319	$11K
76820		<1%	725	$11K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,739	$11K
93321		<1%	178	$11K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,742	$11K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	33	$11K
90715		<1%	3,619	$11K
82570		<1%	2,662	$11K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	4,268	$10K
20526		<1%	58	$10K
84156		<1%	4,039	$10K
88341		<1%	330	$9K
94729		<1%	2,396	$9K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	15	$9K
J7999	Compounded drug, not otherwise classified	<1%	722	$9K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,626	$9K
82272		<1%	456	$9K
99232	Hospital visit by a doctor, follow-up day	<1%	195	$9K
93289		<1%	392	$9K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	389	$8K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	374	$8K
76604		<1%	365	$8K
72050		<1%	117	$8K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,448	$8K
72114		<1%	283	$8K
87563		<1%	1,143	$7K
J9190	Injection, fluorouracil, 500 mg	<1%	923	$7K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,144	$7K
76870		<1%	242	$7K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,659	$7K
89051		<1%	278	$7K
97167		<1%	141	$7K
82803		<1%	2,730	$7K
96411		<1%	711	$7K
J1940	Injection, furosemide, up to 20 mg	<1%	1,588	$7K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	741	$7K
84520		<1%	1,403	$7K
87147		<1%	2,794	$7K
77049		<1%	28	$7K
99213	Doctor's office visit, returning patient (routine)	<1%	428	$7K
82010		<1%	1,724	$7K
82140		<1%	1,018	$7K
84153		<1%	1,023	$6K
93976		<1%	81	$6K
A4648	Tissue marker, implantable, any type, each	<1%	45	$6K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,112	$6K
84550		<1%	2,695	$6K
93246		<1%	402	$6K
72156		<1%	31	$6K
12002		<1%	123	$6K
82274		<1%	894	$6K
91200		<1%	135	$6K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,342	$6K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,767	$6K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	48	$5K
77066	Tomosynthesis, mammo	<1%	1,521	$5K
73700		<1%	144	$5K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,742	$5K
58300		<1%	112	$5K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	358	$5K
85045		<1%	1,362	$5K
86705		<1%	15	$5K
J2060	Injection, lorazepam, 2 mg	<1%	1,764	$5K
84165		<1%	908	$4K
99203	Doctor's office visit, new patient (routine)	<1%	236	$4K
82248		<1%	171	$4K
70487		<1%	13	$4K
J9045	Injection, carboplatin, 50 mg	<1%	604	$4K
97163		<1%	76	$4K
J1953	Injection, levetiracetam, 10 mg	<1%	1,066	$4K
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	237	$4K
J0475	Injection, baclofen, 10 mg	<1%	15	$4K
72158		<1%	29	$4K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	893	$4K
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	118	$4K
76981		<1%	40	$4K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	525	$4K
86038		<1%	829	$4K
72128		<1%	165	$4K
82270		<1%	542	$4K
87522	Neg quan hep c or qual rna	<1%	275	$4K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	1,983	$4K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	<1%	12	$3K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,375	$3K
93299		<1%	133	$3K
86300		<1%	354	$3K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	101	$3K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,280	$3K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	207	$3K
76827		<1%	241	$3K
29125		<1%	274	$3K
78264		<1%	15	$3K
J3480	Injection, potassium chloride, per 2 meq	<1%	543	$3K
84450		<1%	1,166	$3K
76819	Fetal biophysical profile; without non-stress testing	<1%	45	$3K
G0008	Administration of influenza virus vaccine	<1%	1,171	$3K
94664		<1%	27	$3K
86334		<1%	445	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	284	$2K
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	43	$2K
76813		<1%	51	$2K
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	44	$2K
64400		<1%	13	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	143	$2K
82105		<1%	234	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,014	$2K
84134		<1%	413	$2K
73100		<1%	83	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	160	$2K
87106		<1%	927	$2K
83883		<1%	250	$2K
82340		<1%	106	$2K
99204	Doctor's office visit, new patient (more involved)	<1%	20	$2K
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	124	$2K
73140		<1%	43	$2K
74230		<1%	66	$2K
19083		<1%	13	$2K
69200		<1%	12	$2K
73718		<1%	18	$2K
95819		<1%	28	$2K
82375		<1%	15	$2K
92523		<1%	42	$2K
78306		<1%	12	$2K
70360		<1%	30	$2K
74022		<1%	133	$2K
82951		<1%	150	$2K
Q3014	Telehealth originating site facility fee	<1%	2,510	$1K
Q5106	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units	<1%	24	$1K
31500		<1%	30	$1K
86592		<1%	380	$1K
94760		<1%	217	$1K
93225		<1%	27	$1K
92611		<1%	33	$1K
86923		<1%	349	$1K
85660		<1%	195	$1K
99215	Doctor's office visit, returning patient (complex)	<1%	65	$1K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	908	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	389	$1K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	970	$1K
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	31	$1K
84145		<1%	459	$1K
90662		<1%	572	$1K
87581		<1%	3,097	$1K
80164		<1%	85	$1K
C1889	Implantable/insertable device, not otherwise classified	<1%	142	$996.96
76857		<1%	14	$994.01
86160		<1%	339	$863.60
87529		<1%	12	$817.08
84132		<1%	360	$755.11
92610		<1%	56	$742.63
70480		<1%	18	$728.24
93288		<1%	19	$720.33
64615		<1%	15	$703.57
51702		<1%	151	$695.56
J2785	Injection, regadenoson, 0.1 mg	<1%	590	$666.16
83520		<1%	297	$624.95
81002		<1%	46	$592.70
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	22	$573.03
86430		<1%	174	$565.54
C9113	Injection, pantoprazole sodium, per vial	<1%	1,119	$540.61
70490		<1%	14	$536.77
84460		<1%	452	$535.02
J7120	Ringers lactate infusion, up to 1000 cc	<1%	173	$512.11
72157		<1%	14	$500.94
73620		<1%	57	$488.62
J9267	Injection, paclitaxel, 1 mg	<1%	251	$488.11
85014		<1%	47	$480.02
73000		<1%	13	$441.78
87505		<1%	34	$435.96
77076		<1%	14	$406.22
84436		<1%	129	$356.84
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	64	$321.94
93270		<1%	12	$262.25
94660		<1%	16	$254.11
82150		<1%	448	$250.93
81225		<1%	96	$228.93
84295		<1%	153	$218.46
86593		<1%	85	$215.27
64494		<1%	77	$197.38
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	17	$195.88
J0456	Injection, azithromycin, 500 mg	<1%	14	$195.78
84480		<1%	44	$194.17
J2780	Injection, ranitidine hydrochloride, 25 mg	<1%	51	$188.20
C9399	Unclassified drugs or biologicals	<1%	34	$167.62
86480		<1%	17	$145.12
93242		<1%	13	$141.52
84155		<1%	31	$136.88
93226		<1%	13	$130.20
95012		<1%	16	$124.56
87206		<1%	80	$123.25
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	40	$112.13
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	226	$109.09
J3489	Injection, zoledronic acid, 1 mg	<1%	19	$96.87
83721		<1%	29	$86.95
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	62	$76.77
88312		<1%	17	$68.06
83010		<1%	70	$61.25
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	37	$49.18
64495		<1%	59	$48.52
88300		<1%	28	$48.52
86870		<1%	21	$47.82
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	14	$39.40
J1790	Injection, droperidol, up to 5 mg	<1%	364	$38.57
J2800	Injection, methocarbamol, up to 10 ml	<1%	72	$36.00
82947		<1%	43	$24.26
82945		<1%	28	$24.26
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	49	$21.35
82533		<1%	21	$20.11
92526		<1%	32	$16.98
87181		<1%	15	$14.72
84300		<1%	41	$13.24
85384		<1%	33	$11.77
82131		<1%	16	$11.04
84466		<1%	86	$5.30
82784		<1%	14	$4.69
83540		<1%	59	$1.56
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	874	$0.16
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	25	$0.00
82805		0%	15	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	15	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	23	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	72	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	20	$0.00
J8499	Prescription drug, oral, non chemotherapeutic, nos	0%	60	$0.00
87150		0%	28	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	21	$0.00
J7510	Prednisolone oral, per 5 mg	0%	13	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	64	$0.00
V2632	Posterior chamber intraocular lens	0%	101	$0.00
82435		0%	130	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	479	$0.00
90677		0%	17	$0.00
G0009	Administration of pneumococcal vaccine	0%	46	$0.00
90656		0%	40	$0.00
J2150	Injection, mannitol, 25% in 50 ml	0%	25	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	14	$0.00
90732		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOCCHI, DEAN (CHIEF FINANCIAL OFFICER)